S0819

DOI: 10.7937/DT39-JS04 | Image Collection

This collection contains data from the Southwest Oncology Group (SWOG) Clinical Trial NCT00946712, “Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer". Principal Investigator: Roy Herbst. It was sponsored by NCI and performed by the Southwest Oncology Group under...

COVID-19-NY-SBU

DOI: 10.7937/TCIA.BBAG-2923 | Image Collection

This collection of cases was acquired at Stony Brook University from patients who tested positive for COVID-19. The collection includes images from different modalities and organ sites (chest radiographs, chest CTs, brain MRIs, etc.). Radiology imaging data is extremely important in COVID-19 from both a diagnostic and a monitoring perspective, given the crucial nature of COVID-19 pulmonary disease and its rapid...

CMB-AML

DOI: 10.7937/PCTE-6M66 | Image Collection

The Cancer Moonshot Biobank is a National Cancer Institute initiative to support current and future investigations into drug resistance and sensitivity and other NCI-sponsored cancer research initiatives, with an aim of improving researchers' understanding of cancer and how to intervene in cancer initiation and progression. During the course of this study, biospecimens...

RIDER-PHANTOM-PET-CT

DOI: 10.7937/K9/TCIA.2015.8WG2KN4W | Image Collection

The RIDER PHANTOM PET-CT collection consists of repeat measurement PET/CT phantom scan collections carried out under the aegis of the Society of Nuclear Medicine (SNM) to discern the uniformity of clinical imaging instrumentation at various sites. They were obtained in cooperation with SNM as a resource for increased quantitative understanding of machine acquisition, analytic reproducibility and image processing.

The...

POST-NAT-BRCA

DOI: 10.7937/TCIA.2019.4YIBTJNO | Image Collection

Breast cancer (BC) is the second most commonly diagnosed cancer in the U.S. with more than 250,000 new cases of invasive breast cancers reported in 2017. The majority of women with locally advanced and a subset of patients with operable breast cancer will undergo systemic therapy prior to their surgery (neoadjuvant therapy/ NAT) to reduce the size of tumor(s) and possibly further undergo breast conserving surgery....